

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.82269984 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.28127817 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.28127817 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.96507223 |
| 5 | detection of other organism (GO:0098543) | 4.40953779 |
| 6 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.30683384 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 4.28564030 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.23694274 |
| 9 | detection of external biotic stimulus (GO:0098581) | 4.05635537 |
| 10 | detection of bacterium (GO:0016045) | 3.86610979 |
| 11 | neutrophil activation (GO:0042119) | 3.84626366 |
| 12 | positive regulation of mast cell degranulation (GO:0043306) | 3.79762853 |
| 13 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.79762853 |
| 14 | regulation of mast cell degranulation (GO:0043304) | 3.73092667 |
| 15 | regulation of mast cell activation (GO:0033003) | 3.71072379 |
| 16 | granulocyte activation (GO:0036230) | 3.70758500 |
| 17 | macrophage activation (GO:0042116) | 3.67189074 |
| 18 | detection of biotic stimulus (GO:0009595) | 3.64372154 |
| 19 | neutrophil mediated immunity (GO:0002446) | 3.63292820 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61750860 |
| 21 | response to host immune response (GO:0052572) | 3.61750860 |
| 22 | negative T cell selection (GO:0043383) | 3.55056711 |
| 23 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.54925418 |
| 24 | negative thymic T cell selection (GO:0045060) | 3.52738662 |
| 25 | amino sugar catabolic process (GO:0046348) | 3.50927216 |
| 26 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.49050405 |
| 27 | definitive hemopoiesis (GO:0060216) | 3.48573635 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.45596602 |
| 29 | response to interleukin-15 (GO:0070672) | 3.44707411 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 3.39035100 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35541264 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.35541264 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35541264 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35541264 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35541264 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.35541264 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33593838 |
| 38 | negative regulation of phagocytosis (GO:0050765) | 3.32201729 |
| 39 | myeloid leukocyte mediated immunity (GO:0002444) | 3.30558152 |
| 40 | interferon-gamma production (GO:0032609) | 3.25627862 |
| 41 | negative regulation of interleukin-1 production (GO:0032692) | 3.24595306 |
| 42 | tolerance induction (GO:0002507) | 3.21920729 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.21818161 |
| 44 | T cell migration (GO:0072678) | 3.19534702 |
| 45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17791409 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17157856 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17113834 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.16871121 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16594716 |
| 50 | histamine secretion (GO:0001821) | 3.15808344 |
| 51 | regulation of tolerance induction (GO:0002643) | 3.15184175 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12598483 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.12433070 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 3.11101096 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09733595 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.09485984 |
| 57 | activated T cell proliferation (GO:0050798) | 3.09149921 |
| 58 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08268399 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07851223 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.07627393 |
| 61 | leukocyte aggregation (GO:0070486) | 3.07427080 |
| 62 | negative regulation of granulocyte differentiation (GO:0030853) | 3.05672152 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.03289899 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02244671 |
| 65 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.99865216 |
| 66 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99392433 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99227003 |
| 68 | T-helper 1 type immune response (GO:0042088) | 2.98290283 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 2.96225165 |
| 70 | pinocytosis (GO:0006907) | 2.92480016 |
| 71 | regulation of germinal center formation (GO:0002634) | 2.92362966 |
| 72 | germinal center formation (GO:0002467) | 2.90620547 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 2.90269566 |
| 74 | leukocyte degranulation (GO:0043299) | 2.90080477 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88611628 |
| 76 | positive regulation of leukocyte degranulation (GO:0043302) | 2.86865894 |
| 77 | T cell selection (GO:0045058) | 2.86146680 |
| 78 | myeloid leukocyte activation (GO:0002274) | 2.85379762 |
| 79 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85291812 |
| 80 | N-acetylneuraminate metabolic process (GO:0006054) | 2.83613829 |
| 81 | neutrophil chemotaxis (GO:0030593) | 2.82565939 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78451748 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76867880 |
| 84 | immunoglobulin mediated immune response (GO:0016064) | 2.73310677 |
| 85 | DNA unwinding involved in DNA replication (GO:0006268) | 2.71239880 |
| 86 | positive regulation of macrophage differentiation (GO:0045651) | 2.69094339 |
| 87 | regulation of cholesterol storage (GO:0010885) | 2.65649916 |
| 88 | platelet dense granule organization (GO:0060155) | 2.53553216 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 2.53187302 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.52133246 |
| 91 | B cell mediated immunity (GO:0019724) | 2.49933666 |
| 92 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.46101442 |
| 93 | kinetochore organization (GO:0051383) | 2.45996534 |
| 94 | outer ear morphogenesis (GO:0042473) | 2.45870888 |
| 95 | positive regulation of chemokine secretion (GO:0090197) | 2.44489885 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.44444002 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.44444002 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44366239 |
| 99 | germ cell migration (GO:0008354) | 2.41925992 |
| 100 | response to peptidoglycan (GO:0032494) | 2.39101001 |
| 101 | regulation of macrophage differentiation (GO:0045649) | 2.38023625 |
| 102 | phagocytosis, engulfment (GO:0006911) | 2.36671339 |
| 103 | cellular extravasation (GO:0045123) | 2.32334393 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.32327169 |
| 105 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.31696816 |
| 106 | positive regulation of hemostasis (GO:1900048) | 2.29306221 |
| 107 | positive regulation of blood coagulation (GO:0030194) | 2.29306221 |
| 108 | respiratory burst (GO:0045730) | 2.29002052 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28771980 |
| 110 | DNA topological change (GO:0006265) | 2.26855690 |
| 111 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.26492481 |
| 112 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.25840628 |
| 113 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.25623028 |
| 114 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.25459592 |
| 115 | negative regulation of mast cell activation (GO:0033004) | 2.25096770 |
| 116 | ribosomal small subunit assembly (GO:0000028) | 2.23545331 |
| 117 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.23472375 |
| 118 | polyketide metabolic process (GO:0030638) | 2.23431064 |
| 119 | doxorubicin metabolic process (GO:0044598) | 2.23431064 |
| 120 | daunorubicin metabolic process (GO:0044597) | 2.23431064 |
| 121 | detection of molecule of bacterial origin (GO:0032490) | 2.21412985 |
| 122 | positive regulation of coagulation (GO:0050820) | 2.21364537 |
| 123 | regulation of B cell differentiation (GO:0045577) | 2.20850402 |
| 124 | dendritic cell chemotaxis (GO:0002407) | 2.20533974 |
| 125 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.17994351 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.17990252 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 2.14319997 |
| 128 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.12918733 |
| 129 | I-kappaB phosphorylation (GO:0007252) | 2.12284625 |
| 130 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.12116931 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.11658765 |
| 132 | microglial cell activation (GO:0001774) | 2.10912567 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.09482300 |
| 134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.09108727 |
| 135 | response to host (GO:0075136) | 2.09108727 |
| 136 | response to host defenses (GO:0052200) | 2.09108727 |
| 137 | cell proliferation involved in metanephros development (GO:0072203) | 2.08771534 |
| 138 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.07968821 |
| 139 | response to interferon-alpha (GO:0035455) | 2.07783401 |
| 140 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.06847751 |
| 141 | aldehyde catabolic process (GO:0046185) | 2.06787778 |
| 142 | secretory granule organization (GO:0033363) | 2.02900433 |
| 143 | hyaluronan catabolic process (GO:0030214) | 2.02846199 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.02297743 |
| 145 | negative regulation of lipid storage (GO:0010888) | 2.01567042 |
| 146 | antigen processing and presentation via MHC class Ib (GO:0002475) | 1.99900350 |
| 147 | regulation of mononuclear cell migration (GO:0071675) | 1.99636869 |
| 148 | dendritic cell migration (GO:0036336) | 1.98780123 |
| 149 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 1.98498772 |
| 150 | protein carboxylation (GO:0018214) | 1.98074402 |
| 151 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.98074402 |
| 152 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.97999628 |
| 153 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.96661765 |
| 154 | low-density lipoprotein particle clearance (GO:0034383) | 1.95409324 |
| 155 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 1.95302384 |
| 156 | negative regulation of macrophage differentiation (GO:0045650) | 1.95301394 |
| 157 | alpha-linolenic acid metabolic process (GO:0036109) | 1.93273531 |
| 158 | regulation of MHC class II biosynthetic process (GO:0045346) | 1.92913031 |
| 159 | positive regulation of tumor necrosis factor production (GO:0032760) | 1.92412097 |
| 160 | plasma lipoprotein particle clearance (GO:0034381) | 1.92366576 |
| 161 | meiotic chromosome segregation (GO:0045132) | 1.92069354 |
| 162 | endothelial tube morphogenesis (GO:0061154) | 1.91522885 |
| 163 | morphogenesis of an endothelium (GO:0003159) | 1.91522885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.54241258 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12396575 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.10062640 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70666728 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48581449 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40437396 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12157631 |
| 8 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89966959 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.84693363 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.83978794 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70095077 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68324562 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62961955 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52492990 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.51550785 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.49693737 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47852387 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44430477 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.41909979 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34607425 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.33607678 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26646655 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.12220918 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09750801 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08079959 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06540104 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99865083 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98161891 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95951101 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93354257 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89877490 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87884404 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87619950 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86472234 |
| 35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85392364 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84843895 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84138738 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83985992 |
| 39 | * MYC_22102868_ChIP-Seq_BL_Human | 1.79369100 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77867689 |
| 41 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77397371 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77382753 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74420030 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.73838129 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72536942 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68305864 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67494396 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66455399 |
| 49 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65110549 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64173690 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60558762 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.59743831 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.58311946 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57733058 |
| 55 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.56837333 |
| 56 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.55427852 |
| 57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55099369 |
| 58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51426828 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47997305 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.45273139 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43711091 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43558202 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43157809 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37810957 |
| 65 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36559540 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36045088 |
| 67 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35396000 |
| 68 | * MYB_26560356_Chip-Seq_TH1_Human | 1.34661532 |
| 69 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33534756 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33419513 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31961967 |
| 72 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30340783 |
| 73 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29842105 |
| 74 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29730589 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29632492 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28874728 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28071128 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26122673 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25908079 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23147526 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22809840 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20454000 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18830379 |
| 84 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18688993 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15839328 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14858197 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14856153 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14392043 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11239580 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.09708768 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08149447 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07846208 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.04243388 |
| 94 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03614858 |
| 95 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.03402389 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02384025 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02084218 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01800963 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01132703 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00940679 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00734805 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00150388 |
| 103 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99144498 |
| 104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98141751 |
| 105 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97486299 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96460325 |
| 107 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95549554 |
| 108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95356754 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93948901 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93138852 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92840655 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92301262 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91395815 |
| 114 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.91022493 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90804497 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.90497531 |
| 117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87896970 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87249208 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87012431 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86952936 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86308108 |
| 122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86157569 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85851081 |
| 124 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85192299 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84790385 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84567140 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81889566 |
| 128 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81595662 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81438604 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81019312 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80589598 |
| 132 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79360426 |
| 133 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76535842 |
| 134 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76004556 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74198612 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73284836 |
| 137 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72917089 |
| 138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.72698408 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71446193 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70131747 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67534580 |
| 142 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.67332087 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64903835 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64383525 |
| 145 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64360271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003172_abnormal_lysosome_physiology | 2.98060155 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.74613258 |
| 3 | MP0003436_decreased_susceptibility_to | 2.47597588 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.28615765 |
| 5 | MP0002009_preneoplasia | 2.23208858 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.17866844 |
| 7 | MP0006054_spinal_hemorrhage | 2.05465423 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 2.01420006 |
| 9 | MP0001879_abnormal_lymphatic_vessel | 2.01146447 |
| 10 | MP0002419_abnormal_innate_immunity | 1.95096886 |
| 11 | MP0003690_abnormal_glial_cell | 1.94334219 |
| 12 | MP0009785_altered_susceptibility_to | 1.90521861 |
| 13 | MP0010368_abnormal_lymphatic_system | 1.90232715 |
| 14 | MP0000569_abnormal_digit_pigmentation | 1.87070796 |
| 15 | MP0002396_abnormal_hematopoietic_system | 1.84741953 |
| 16 | MP0008007_abnormal_cellular_replicative | 1.83280637 |
| 17 | MP0009278_abnormal_bone_marrow | 1.81023964 |
| 18 | MP0003724_increased_susceptibility_to | 1.78691108 |
| 19 | MP0009697_abnormal_copulation | 1.78548469 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.71192128 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.70775532 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.70729971 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.70289711 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.70132241 |
| 25 | MP0000604_amyloidosis | 1.68917483 |
| 26 | MP0005025_abnormal_response_to | 1.68226094 |
| 27 | MP0005671_abnormal_response_to | 1.67803410 |
| 28 | MP0006082_CNS_inflammation | 1.67257212 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.66928716 |
| 30 | MP0004947_skin_inflammation | 1.62287779 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.60637706 |
| 32 | MP0008260_abnormal_autophagy | 1.59204765 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.57425850 |
| 34 | MP0000343_altered_response_to | 1.55684072 |
| 35 | MP0001800_abnormal_humoral_immune | 1.55434143 |
| 36 | MP0003303_peritoneal_inflammation | 1.54157883 |
| 37 | MP0003787_abnormal_imprinting | 1.53164806 |
| 38 | MP0003075_altered_response_to | 1.50748331 |
| 39 | MP0000685_abnormal_immune_system | 1.50563322 |
| 40 | MP0002723_abnormal_immune_serum | 1.50482278 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.45552670 |
| 42 | MP0001819_abnormal_immune_cell | 1.44915752 |
| 43 | MP0009053_abnormal_anal_canal | 1.43606394 |
| 44 | MP0001853_heart_inflammation | 1.41891765 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.41569511 |
| 46 | MP0002405_respiratory_system_inflammati | 1.41343986 |
| 47 | MP0004381_abnormal_hair_follicle | 1.41002487 |
| 48 | MP0003195_calcinosis | 1.37816571 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.35882075 |
| 50 | MP0003279_aneurysm | 1.33762602 |
| 51 | MP0002398_abnormal_bone_marrow | 1.33665927 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.32830325 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.32830325 |
| 54 | MP0005365_abnormal_bile_salt | 1.31391104 |
| 55 | MP0005248_abnormal_Harderian_gland | 1.30256973 |
| 56 | MP0004883_abnormal_blood_vessel | 1.30137286 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.29552044 |
| 58 | MP0008877_abnormal_DNA_methylation | 1.26518700 |
| 59 | MP0005310_abnormal_salivary_gland | 1.25571781 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.23564127 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.22917997 |
| 62 | MP0001790_abnormal_immune_system | 1.22915279 |
| 63 | MP0005387_immune_system_phenotype | 1.22915279 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.21739969 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.21506106 |
| 66 | MP0000716_abnormal_immune_system | 1.20483908 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.20356001 |
| 68 | MP0002722_abnormal_immune_system | 1.19540855 |
| 69 | MP0003186_abnormal_redox_activity | 1.19402815 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.18984420 |
| 71 | MP0000490_abnormal_crypts_of | 1.18153065 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.16951548 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.16626806 |
| 74 | MP0005670_abnormal_white_adipose | 1.15316859 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.12585297 |
| 76 | MP0003077_abnormal_cell_cycle | 1.11605071 |
| 77 | MP0008469_abnormal_protein_level | 1.11468442 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.11297590 |
| 79 | MP0002429_abnormal_blood_cell | 1.11170235 |
| 80 | MP0001915_intracranial_hemorrhage | 1.11058358 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.07410759 |
| 82 | MP0003828_pulmonary_edema | 1.06344848 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.06027505 |
| 84 | MP0000767_abnormal_smooth_muscle | 1.04095587 |
| 85 | MP0005360_urolithiasis | 1.04088956 |
| 86 | MP0010307_abnormal_tumor_latency | 1.03327124 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.02423175 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.01462860 |
| 89 | MP0003252_abnormal_bile_duct | 1.01249333 |
| 90 | MP0009764_decreased_sensitivity_to | 1.00196663 |
| 91 | MP0009763_increased_sensitivity_to | 0.99526468 |
| 92 | MP0000598_abnormal_liver_morphology | 0.99156119 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.96528307 |
| 94 | MP0003943_abnormal_hepatobiliary_system | 0.96326533 |
| 95 | MP0004510_myositis | 0.95978796 |
| 96 | MP0000920_abnormal_myelination | 0.94031670 |
| 97 | MP0000858_altered_metastatic_potential | 0.93888166 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.93222074 |
| 99 | MP0000609_abnormal_liver_physiology | 0.92330051 |
| 100 | MP0009840_abnormal_foam_cell | 0.91925912 |
| 101 | MP0002933_joint_inflammation | 0.91445884 |
| 102 | MP0005390_skeleton_phenotype | 0.90739372 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.90587684 |
| 104 | MP0003448_altered_tumor_morphology | 0.88798316 |
| 105 | MP0008057_abnormal_DNA_replication | 0.87920986 |
| 106 | MP0002938_white_spotting | 0.87504440 |
| 107 | MP0000249_abnormal_blood_vessel | 0.87424487 |
| 108 | MP0003795_abnormal_bone_structure | 0.87348185 |
| 109 | MP0000733_abnormal_muscle_development | 0.85967757 |
| 110 | MP0005166_decreased_susceptibility_to | 0.85925843 |
| 111 | MP0009115_abnormal_fat_cell | 0.84331163 |
| 112 | MP0008058_abnormal_DNA_repair | 0.83907428 |
| 113 | MP0002128_abnormal_blood_circulation | 0.83584757 |
| 114 | MP0005023_abnormal_wound_healing | 0.83382313 |
| 115 | MP0002006_tumorigenesis | 0.82686784 |
| 116 | MP0000371_diluted_coat_color | 0.81204073 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80301258 |
| 118 | MP0003385_abnormal_body_wall | 0.79854906 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.79396532 |
| 120 | MP0001851_eye_inflammation | 0.79184004 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.78668515 |
| 122 | MP0002282_abnormal_trachea_morphology | 0.78172820 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.76704022 |
| 124 | MP0002135_abnormal_kidney_morphology | 0.76395016 |
| 125 | MP0005164_abnormal_response_to | 0.75110255 |
| 126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74570595 |
| 127 | MP0006072_abnormal_retinal_apoptosis | 0.73725855 |
| 128 | MP0003866_abnormal_defecation | 0.72293941 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.70438406 |
| 130 | MP0005388_respiratory_system_phenotype | 0.67015539 |
| 131 | MP0002133_abnormal_respiratory_system | 0.67015539 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.62172907 |
| 133 | MP0003632_abnormal_nervous_system | 0.61865086 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.61362134 |
| 135 | MP0003329_amyloid_beta_deposits | 0.57573781 |
| 136 | MP0002090_abnormal_vision | 0.56521804 |
| 137 | MP0003633_abnormal_nervous_system | 0.55929265 |
| 138 | MP0002132_abnormal_respiratory_system | 0.52750921 |
| 139 | MP0005647_abnormal_sex_gland | 0.52501048 |
| 140 | MP0005253_abnormal_eye_physiology | 0.49038773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.72996898 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.72996898 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.72996898 |
| 4 | Stomatitis (HP:0010280) | 4.65295053 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.17322271 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13347907 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.92672482 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.73519582 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.54119711 |
| 10 | Myositis (HP:0100614) | 3.40008231 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.39087896 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.39087896 |
| 13 | Mutism (HP:0002300) | 3.38367290 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.36271158 |
| 15 | Loss of speech (HP:0002371) | 3.29549182 |
| 16 | Hematochezia (HP:0002573) | 3.21288200 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.10404643 |
| 18 | Glomerulonephritis (HP:0000099) | 3.04537073 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 3.03715513 |
| 20 | Complement deficiency (HP:0004431) | 2.97010952 |
| 21 | Disinhibition (HP:0000734) | 2.90103609 |
| 22 | Hemoptysis (HP:0002105) | 2.89009196 |
| 23 | Encephalitis (HP:0002383) | 2.86506975 |
| 24 | Keratoconjunctivitis (HP:0001096) | 2.84932326 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79895568 |
| 26 | Pulmonary infiltrates (HP:0002113) | 2.79263125 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.73009398 |
| 28 | Thrombocytosis (HP:0001894) | 2.71138159 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.69909446 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 2.69784138 |
| 31 | Joint hemorrhage (HP:0005261) | 2.67903098 |
| 32 | Spinal cord lesions (HP:0100561) | 2.65253319 |
| 33 | Syringomyelia (HP:0003396) | 2.65253319 |
| 34 | Agnosia (HP:0010524) | 2.64870341 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.64726981 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62022001 |
| 37 | Aortic aneurysm (HP:0004942) | 2.61418385 |
| 38 | Recurrent viral infections (HP:0004429) | 2.60130492 |
| 39 | Vasculitis (HP:0002633) | 2.59469364 |
| 40 | Orchitis (HP:0100796) | 2.59410582 |
| 41 | Short 4th metacarpal (HP:0010044) | 2.58577028 |
| 42 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.58577028 |
| 43 | Amyloidosis (HP:0011034) | 2.58282082 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.58226937 |
| 45 | Abnormality of complement system (HP:0005339) | 2.54963661 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.53856808 |
| 47 | Recurrent skin infections (HP:0001581) | 2.52678696 |
| 48 | Pustule (HP:0200039) | 2.44529988 |
| 49 | Chest pain (HP:0100749) | 2.42935932 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.42838194 |
| 51 | Retinal atrophy (HP:0001105) | 2.41438511 |
| 52 | Increased IgE level (HP:0003212) | 2.40325039 |
| 53 | Impaired platelet aggregation (HP:0003540) | 2.35771793 |
| 54 | Abnormal platelet function (HP:0011869) | 2.35771793 |
| 55 | Arterial tortuosity (HP:0005116) | 2.34513900 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34095067 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34095067 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34095067 |
| 59 | Bicuspid aortic valve (HP:0001647) | 2.31214604 |
| 60 | Granulocytopenia (HP:0001913) | 2.30455743 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.27601096 |
| 62 | B lymphocytopenia (HP:0010976) | 2.27601096 |
| 63 | Cellulitis (HP:0100658) | 2.27598484 |
| 64 | Spondylolisthesis (HP:0003302) | 2.26892379 |
| 65 | Myocardial infarction (HP:0001658) | 2.26139552 |
| 66 | Abnormality of eosinophils (HP:0001879) | 2.24401134 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23499706 |
| 68 | Deep venous thrombosis (HP:0002625) | 2.23469248 |
| 69 | Abnormality of the 4th metacarpal (HP:0010012) | 2.21160161 |
| 70 | Polyneuropathy (HP:0001271) | 2.20889533 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.20345833 |
| 72 | Pulmonary embolism (HP:0002204) | 2.19439240 |
| 73 | Episodic fever (HP:0001954) | 2.19314643 |
| 74 | Aortic dissection (HP:0002647) | 2.17179180 |
| 75 | Petechiae (HP:0000967) | 2.15997891 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.13812309 |
| 77 | Vascular tortuosity (HP:0004948) | 2.13455077 |
| 78 | Inappropriate behavior (HP:0000719) | 2.12903088 |
| 79 | Optic neuritis (HP:0100653) | 2.10499056 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.10499056 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.10119840 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10119840 |
| 83 | Protrusio acetabuli (HP:0003179) | 2.09483592 |
| 84 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08892694 |
| 85 | Biconcave vertebral bodies (HP:0004586) | 2.08706335 |
| 86 | T lymphocytopenia (HP:0005403) | 2.07002366 |
| 87 | Gingival bleeding (HP:0000225) | 2.06632317 |
| 88 | Osteomyelitis (HP:0002754) | 2.05053977 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 2.04538024 |
| 90 | Panhypogammaglobulinemia (HP:0003139) | 2.04237246 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.01533404 |
| 92 | Aplastic anemia (HP:0001915) | 2.00681638 |
| 93 | Hypoplasia of the thymus (HP:0000778) | 2.00141529 |
| 94 | Increased IgM level (HP:0003496) | 1.99168011 |
| 95 | Lymphopenia (HP:0001888) | 1.98652910 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.97252627 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.96543673 |
| 98 | Colon cancer (HP:0003003) | 1.95563060 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.95428948 |
| 100 | Recurrent pneumonia (HP:0006532) | 1.94713293 |
| 101 | Amaurosis fugax (HP:0100576) | 1.92713079 |
| 102 | Epistaxis (HP:0000421) | 1.92355022 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.91418310 |
| 104 | Thoracic kyphosis (HP:0002942) | 1.90546646 |
| 105 | Diminished motivation (HP:0000745) | 1.90521154 |
| 106 | Progressive neurologic deterioration (HP:0002344) | 1.90453952 |
| 107 | Meningitis (HP:0001287) | 1.89995858 |
| 108 | Memory impairment (HP:0002354) | 1.88444475 |
| 109 | Mucosal telangiectasiae (HP:0100579) | 1.88392906 |
| 110 | Premature loss of primary teeth (HP:0006323) | 1.87928097 |
| 111 | Leukocytosis (HP:0001974) | 1.87616483 |
| 112 | IgM deficiency (HP:0002850) | 1.87072909 |
| 113 | Arterial thrombosis (HP:0004420) | 1.86089415 |
| 114 | Abnormal platelet volume (HP:0011876) | 1.85155550 |
| 115 | Stomach cancer (HP:0012126) | 1.85064452 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83752466 |
| 117 | Apathy (HP:0000741) | 1.83616966 |
| 118 | Anorexia (HP:0002039) | 1.82551803 |
| 119 | Acute myeloid leukemia (HP:0004808) | 1.82057060 |
| 120 | Hypercholesterolemia (HP:0003124) | 1.82005337 |
| 121 | Upper motor neuron abnormality (HP:0002127) | 1.81240823 |
| 122 | Periodontitis (HP:0000704) | 1.80934026 |
| 123 | Sepsis (HP:0100806) | 1.80809722 |
| 124 | Abnormality of the lumbar spine (HP:0100712) | 1.80646031 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.80164352 |
| 126 | Thyroiditis (HP:0100646) | 1.79296238 |
| 127 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79275139 |
| 128 | Obstructive lung disease (HP:0006536) | 1.79275139 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.79224571 |
| 130 | Combined immunodeficiency (HP:0005387) | 1.79045628 |
| 131 | Striae distensae (HP:0001065) | 1.78916495 |
| 132 | Colitis (HP:0002583) | 1.78322950 |
| 133 | Purpura (HP:0000979) | 1.78203303 |
| 134 | Hypergammaglobulinemia (HP:0010702) | 1.78139669 |
| 135 | Nephritis (HP:0000123) | 1.76270406 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.76110144 |
| 137 | Renal duplication (HP:0000075) | 1.74622807 |
| 138 | Gingivitis (HP:0000230) | 1.73596949 |
| 139 | Prostate neoplasm (HP:0100787) | 1.73044699 |
| 140 | Urticaria (HP:0001025) | 1.70728504 |
| 141 | Severe combined immunodeficiency (HP:0004430) | 1.70343050 |
| 142 | Thrombophlebitis (HP:0004418) | 1.69898641 |
| 143 | Abnormality of T cells (HP:0002843) | 1.68932957 |
| 144 | Eosinophilia (HP:0001880) | 1.67708425 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.67467627 |
| 146 | Increased density of long bones (HP:0006392) | 1.66678888 |
| 147 | Mitral valve prolapse (HP:0001634) | 1.65610031 |
| 148 | Soft skin (HP:0000977) | 1.64781956 |
| 149 | Basal ganglia calcification (HP:0002135) | 1.64555834 |
| 150 | Esophageal varix (HP:0002040) | 1.64547121 |
| 151 | Mesangial abnormality (HP:0001966) | 1.62917553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.01311662 |
| 2 | TGFBR2 | 3.93896461 |
| 3 | MAP3K10 | 2.43668500 |
| 4 | TGFBR1 | 2.42882308 |
| 5 | FES | 2.42518417 |
| 6 | CAMKK2 | 2.41540995 |
| 7 | NEK9 | 2.38092237 |
| 8 | MAP4K1 | 2.37241592 |
| 9 | FGR | 2.25431874 |
| 10 | KIT | 2.25261538 |
| 11 | TXK | 2.23262533 |
| 12 | KSR1 | 2.17183165 |
| 13 | KSR2 | 2.09933571 |
| 14 | GRK6 | 1.97275298 |
| 15 | IRAK4 | 1.95958986 |
| 16 | RPS6KA4 | 1.92113893 |
| 17 | TBK1 | 1.88956002 |
| 18 | ZAP70 | 1.86100033 |
| 19 | STK10 | 1.86038805 |
| 20 | PKN2 | 1.82877480 |
| 21 | ERN1 | 1.78523641 |
| 22 | TYK2 | 1.72667731 |
| 23 | CDK6 | 1.71566432 |
| 24 | BTK | 1.68743400 |
| 25 | CSF1R | 1.66598567 |
| 26 | PAK4 | 1.61990140 |
| 27 | TEC | 1.59475832 |
| 28 | BLK | 1.56733568 |
| 29 | MAP2K3 | 1.55985333 |
| 30 | CDC7 | 1.50906781 |
| 31 | MKNK1 | 1.48573736 |
| 32 | FLT3 | 1.32316385 |
| 33 | SRPK1 | 1.31845134 |
| 34 | TRIB3 | 1.30631971 |
| 35 | IRAK3 | 1.30619482 |
| 36 | SIK1 | 1.29856203 |
| 37 | KDR | 1.29355914 |
| 38 | CAMK1D | 1.26603150 |
| 39 | NEK2 | 1.26034984 |
| 40 | GRK7 | 1.24695556 |
| 41 | SGK2 | 1.23382263 |
| 42 | TIE1 | 1.23028777 |
| 43 | MAP3K2 | 1.22297764 |
| 44 | NME2 | 1.21619379 |
| 45 | PASK | 1.20528292 |
| 46 | YES1 | 1.19927144 |
| 47 | EEF2K | 1.15810434 |
| 48 | JAK3 | 1.15314912 |
| 49 | RAF1 | 1.15248508 |
| 50 | TNK2 | 1.13855069 |
| 51 | BMPR2 | 1.13580893 |
| 52 | CLK1 | 1.12517456 |
| 53 | ITK | 1.11760622 |
| 54 | CDK8 | 1.10643923 |
| 55 | ACVR1B | 1.10622291 |
| 56 | TAOK2 | 1.08960400 |
| 57 | EPHA3 | 1.07091719 |
| 58 | ERBB3 | 1.05660056 |
| 59 | DYRK3 | 1.03226304 |
| 60 | PIM1 | 1.02841625 |
| 61 | SCYL2 | 1.02174152 |
| 62 | BCKDK | 1.02119656 |
| 63 | WEE1 | 1.01757388 |
| 64 | MELK | 1.00730937 |
| 65 | LYN | 1.00111220 |
| 66 | IKBKB | 0.96559653 |
| 67 | SIK3 | 0.95633741 |
| 68 | STK4 | 0.95569750 |
| 69 | RIPK1 | 0.94973690 |
| 70 | CDK19 | 0.94255832 |
| 71 | MAP3K14 | 0.90023644 |
| 72 | CDK4 | 0.89679345 |
| 73 | IKBKE | 0.89131522 |
| 74 | MAP3K1 | 0.87879398 |
| 75 | MKNK2 | 0.87728773 |
| 76 | PTK6 | 0.87388277 |
| 77 | MAP3K13 | 0.87225910 |
| 78 | CHUK | 0.86806224 |
| 79 | MAPK7 | 0.86658107 |
| 80 | LCK | 0.86046076 |
| 81 | EPHB2 | 0.85866697 |
| 82 | SGK3 | 0.85413821 |
| 83 | BRSK2 | 0.84935282 |
| 84 | LRRK2 | 0.84432396 |
| 85 | HCK | 0.82875639 |
| 86 | CDK9 | 0.82504534 |
| 87 | ATR | 0.81221385 |
| 88 | CDK3 | 0.79304499 |
| 89 | CCNB1 | 0.79011591 |
| 90 | SYK | 0.78732157 |
| 91 | NLK | 0.76928799 |
| 92 | IRAK1 | 0.76899684 |
| 93 | BUB1 | 0.74451856 |
| 94 | SGK223 | 0.73981424 |
| 95 | SGK494 | 0.73981424 |
| 96 | EIF2AK2 | 0.73486129 |
| 97 | PRPF4B | 0.73450730 |
| 98 | PTK2B | 0.72797217 |
| 99 | LATS1 | 0.71312182 |
| 100 | JAK2 | 0.69919865 |
| 101 | MAP3K3 | 0.69287432 |
| 102 | JAK1 | 0.68851103 |
| 103 | FGFR4 | 0.68407778 |
| 104 | EPHB1 | 0.67288587 |
| 105 | CAMK4 | 0.66552792 |
| 106 | DYRK1B | 0.66435695 |
| 107 | AURKB | 0.66142473 |
| 108 | TAOK1 | 0.64591962 |
| 109 | STK3 | 0.63443085 |
| 110 | MATK | 0.63199703 |
| 111 | MAP3K11 | 0.62943787 |
| 112 | IGF1R | 0.61895202 |
| 113 | WNK3 | 0.61700981 |
| 114 | MARK3 | 0.60172106 |
| 115 | CAMKK1 | 0.59723494 |
| 116 | ERBB2 | 0.59294630 |
| 117 | MAP3K8 | 0.58525871 |
| 118 | PIM2 | 0.55518695 |
| 119 | ABL1 | 0.52146332 |
| 120 | PDGFRB | 0.51938903 |
| 121 | CDK7 | 0.51888981 |
| 122 | CSK | 0.51757212 |
| 123 | FYN | 0.51515112 |
| 124 | FGFR3 | 0.51499090 |
| 125 | NUAK1 | 0.50361455 |
| 126 | TLK1 | 0.50254837 |
| 127 | PRKCQ | 0.50144281 |
| 128 | RPS6KL1 | 0.49253428 |
| 129 | RPS6KC1 | 0.49253428 |
| 130 | RPS6KA6 | 0.48203914 |
| 131 | DDR2 | 0.48189062 |
| 132 | IRAK2 | 0.48016958 |
| 133 | RET | 0.47324347 |
| 134 | PAK2 | 0.47011553 |
| 135 | RPS6KB2 | 0.46833892 |
| 136 | PIK3CG | 0.45048056 |
| 137 | HIPK2 | 0.44719404 |
| 138 | VRK1 | 0.44661002 |
| 139 | MOS | 0.43694450 |
| 140 | MAP2K6 | 0.43233965 |
| 141 | PDK1 | 0.42635137 |
| 142 | TAOK3 | 0.41004058 |
| 143 | PLK1 | 0.40934006 |
| 144 | FRK | 0.40554525 |
| 145 | ADRBK2 | 0.40020041 |
| 146 | MAP3K7 | 0.39507029 |
| 147 | EGFR | 0.39419669 |
| 148 | CAMK1G | 0.39412157 |
| 149 | MARK2 | 0.36674821 |
| 150 | STK24 | 0.35999546 |
| 151 | CSNK1G2 | 0.34194507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02455511 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36942144 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16544526 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13397694 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.12457218 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10964064 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05756365 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87343798 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86450901 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.82900272 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76405373 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.74793871 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66792204 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60759579 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.58597989 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53395271 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50102098 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47514850 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.45468234 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44172650 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43781986 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.40793783 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40683786 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.38412928 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38260248 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36939394 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.32372800 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31357117 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.30664699 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27141583 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22641472 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.22536531 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.21436853 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16013608 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15924242 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15542218 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13294669 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.12649820 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11150036 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09911163 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08772898 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08111396 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07406895 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06802255 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.06562808 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06525147 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06503295 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.06240706 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.04976657 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04661456 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04277143 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.02395387 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01692400 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99944208 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.99907079 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98953994 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97466825 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93959000 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93624521 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.92673471 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92667943 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91826110 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.89797855 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.89787128 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.87100040 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86367042 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85553500 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85010192 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84877387 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84683072 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84229689 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84143238 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.83126115 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82842144 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82722854 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82510919 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81606416 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80946571 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79847405 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78911807 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78338071 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.77804200 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75638324 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75301500 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75011097 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74795222 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74212976 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72545784 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71330645 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70391932 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70369665 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65160034 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64628414 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64514056 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64402574 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.64298583 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64218841 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64101899 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63760622 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63430533 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63058762 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62397300 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.61437215 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61292792 |
| 105 | Protein export_Homo sapiens_hsa03060 | 0.61191110 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60910217 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60493813 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.59860909 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58949377 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.58763885 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.58082605 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55900066 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55130871 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54491155 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.54246994 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.53586073 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52394261 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50748543 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50528133 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.50018356 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49278707 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48649214 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47912687 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47672783 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47437316 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.45623223 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44960345 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40726705 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39616454 |
| 130 | Renin secretion_Homo sapiens_hsa04924 | 0.39318220 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36468580 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36277186 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35730495 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31368701 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30100836 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29801597 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29793759 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28622638 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28385751 |
| 140 | Prostate cancer_Homo sapiens_hsa05215 | 0.23454265 |
| 141 | Long-term depression_Homo sapiens_hsa04730 | 0.22307758 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22213547 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21962696 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17665528 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16386893 |

